EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Uni-Bio Science Group's Enterprise Value is HK$340.0 Mil.
Uni-Bio Science Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$98.8 Mil. Therefore, Uni-Bio Science Group's EV-to-FCF for today is 3.44.
The historical rank and industry rank for Uni-Bio Science Group's EV-to-FCF or its related term are showing as below:
HKSE:00690'
s EV-to-FCF Range Over the Past 10 Years
Min: -25.17 Med: -6.43 Max: 153.21
Current: 3.44
During the past 13 years, the highest EV-to-FCF of Uni-Bio Science Group was 153.21. The lowest was -25.17. And the median was -6.43.
HKSE:00690's EV-to-FCF is ranked better than 53.48% of 402
companies
in the Biotechnology industry
Industry Median: 5.935
vs HKSE:00690: 3.44
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Uni-Bio Science Group's EV-to-FCF
For the Biotechnology subindustry, Uni-Bio Science Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uni-Bio Science Group's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Uni-Bio Science Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Uni-Bio Science Group's EV-to-FCF falls into.
Uni-Bio Science Group's current Enterprise Value is HK$340.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Uni-Bio Science Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$98.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Uni-Bio Science Group (HKSE:00690) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Uni-Bio Science Group's PE Ratio for today is calculated as:
Uni-Bio Science Group's share price for today is HK$0.067.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Uni-Bio Science Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.011.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Uni-Bio Science Group EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Uni-Bio Science Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Uni-Bio Science Group (HKSE:00690) Business Description
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00690 has been successfully added to your 